This technology is a composition for inducing neuroectodermal differentiation of stem cells, comprising a TGF-β receptor ALK5 inhibitor, a BMP inhibitor, and an endocytosis inhibitor.
While methods for efficiently differentiating stem cells into neuroectoderm are essential for neural cell therapy, conventional methods have shown low efficiency.
This technology promotes neuroectodermal differentiation by treating human embryonic stem cells and induced pluripotent stem cells with three types of inhibitors, and can be provided as a composition or in kit form.
N/A
